EU Gives Pfizer Green Light For $43B Seagen Takeover
The European Commission has unconditionally approved the proposed $43 billion acquisition of global cancer biotechnology company Seagen by Pfizer after concluding the deal will not create any competition concerns, paving the way...To view the full article, register now.
Already a subscriber? Click here to view full article